by Avery Zimmerman | Mar 20, 2020 | News
Canton, Mich. (March 20, 2020) — MMS Holdings (MMS) – an award-winning, data-focused CRO – announced today that it is offering a USD1M award toward the development of a vaccine for COVID-19, also known as the coronavirus. The award is being offered in the form of data...
by Avery Zimmerman | Oct 3, 2019 | Blog
by MMS Holdings and MichBio.org This webinar is intended to help guide individuals towards a better understanding of core concepts and requirements for using real-world data (RWD). Here, we will delve into how one can derive and utilize real-world evidence (RWE) in...
by Avery Zimmerman | Aug 22, 2019 | Blog
The idea and practice of using real world data in the pharmaceutical industry has driven much conversation as of late. As groups like the Health Analytics Collective begin to bring game-changing methodologies to the marketplace, we sat down with Vijay Ivaturi,...
by Avery Zimmerman | Jun 13, 2019 | Blog
New and updated regulatory guidances from the US Food and Drug Administration (FDA), European Medicines Agency (EMA), Pharmaceuticals and Medical Devices Agency (PMDA) in Japan, and other global health authorities are continually being release. These guidances are...
by Avery Zimmerman | Feb 28, 2019 | Blog
Rare diseases are often overlooked, but they affect many individuals. There may be as many as 7,000 rare diseases affecting approximately 25-30 million people in the US alone, according to the National Institutes of Health (NIH). Rare diseases are defined as...
